Adalimumab 80MG/0,8ML (Yuflyma) INJ CAN 0,8ML SC, RITUximab (Truxima) 100mg/10ml sol inj fr IV, RITUximab (Truxima) 500mg/50ml sol inj fr IV e Adalimumab 40 mg/0.4 ml (Yuflyma) inj Can 0.4 ml SC

ID 10981122 · Portal BASE
Price
Base Price
€0 .00
Effective Price
€363,230 .00
Contract Details
Contract Type
Aquisição de bens móveis
Procedure
Ajuste Direto Regime Geral
CPV Code
33600000
Location
Portugal, Braga, Braga
Bidder Count
—
Winner
PHARMAKERN PORTUGAL, LDA.
NIF 507002571
Company
Dates
Publication
21 Oct 2024
Celebration
01 Feb 2024
Contracting Entity
Unidade Local de Saúde de Braga, EPE
NIF 515545180
Public body
Data Source
Portal BASE
Api · synced 2026-04-17
Risk Flags
Score 90 · HIGH RISK
A1 · Repeat Direct Award
A1_REPEAT_DIRECT_AWARD
HIGH
Authority
1963
Supplier
309
Number of Awards
11
Rule
A1 repeat direct award: 11 awards within 36 months
Detected 2026-03-06
A2 · Late Publication
A2_PUBLICATION_AFTER_CELEBRATION
HIGH
Publication Date
21 Oct 2024
Signing Date
01 Feb 2024
Days Late
263
Rule
A2/A3 late publication: 263 days after signing (threshold: 10)
Detected 2026-03-06